- Home
- ZTS vs WELL Comparison
ZTS vs WELL Comparison
Compare ZTS & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTS
- WELL
- Stock Information
- Founded
- ZTS 1952
- WELL 1970
- Country
- ZTS United States
- WELL United States
- Employees
- ZTS N/A
- WELL N/A
- Industry
- ZTS Biotechnology: Pharmaceutical Preparations
- WELL Real Estate Investment Trusts
- Sector
- ZTS Health Care
- WELL Real Estate
- Exchange
- ZTS Nasdaq
- WELL Nasdaq
- Market Cap
- ZTS 80.4B
- WELL 85.4B
- IPO Year
- ZTS 2013
- WELL N/A
- Fundamental
- Price
- ZTS $163.87
- WELL $124.76
- Analyst Decision
- ZTS Strong Buy
- WELL Buy
- Analyst Count
- ZTS 9
- WELL 10
- Target Price
- ZTS $220.33
- WELL $124.25
- AVG Volume (30 Days)
- ZTS 2.6M
- WELL 3.5M
- Earning Date
- ZTS 02-11-2025
- WELL 02-11-2025
- Dividend Yield
- ZTS 1.05%
- WELL 2.15%
- EPS Growth
- ZTS 8.38
- WELL 209.97
- EPS
- ZTS 5.32
- WELL 1.56
- Revenue
- ZTS $9,152,000,000.00
- WELL $7,555,548,000.00
- Revenue This Year
- ZTS $9.48
- WELL N/A
- Revenue Next Year
- ZTS $4.92
- WELL $14.19
- P/E Ratio
- ZTS $31.00
- WELL $80.00
- Revenue Growth
- ZTS 9.33
- WELL 20.26
- 52 Week Low
- ZTS $144.80
- WELL $85.40
- 52 Week High
- ZTS $200.53
- WELL $140.75
- Technical
- Relative Strength Index (RSI)
- ZTS 29.38
- WELL 31.87
- Support Level
- ZTS $163.37
- WELL $127.90
- Resistance Level
- ZTS $181.85
- WELL $131.02
- Average True Range (ATR)
- ZTS 3.88
- WELL 2.56
- MACD
- ZTS -1.22
- WELL -0.90
- Stochastic Oscillator
- ZTS 5.06
- WELL 13.57
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
About WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,137 in-place properties spread across the senior housing, medical office, and skilled nursing/post-acute care sectors. The portfolio includes over 100 properties in both Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.